TickerFacts.

Vertex Pharmaceuticals Inc (VRTX): Share Repurchases

Annual figures by period end, from SEC filings.

$2.02B
Year ended 2025-12-31
$2.01B
Trailing 12 months to 2026-06-30
+30.2%
5-year compound annual growth
2016-12-31: $02017-12-31: $02018-12-31: $350.04M2019-12-31: $186.00M2020-12-31: $539.10M2021-12-31: $1.43B2022-12-31: $02023-12-31: $427.60M2024-12-31: $1.18B2025-12-31: $2.02B$2.02B
2016-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$2.02B+71.4%2026-02-13, From 2025-01-01
2024-12-31$1.18B+175.3%2026-02-13, From 2024-01-01
2023-12-31$427.60Mn/a2026-02-13, From 2023-01-01
2022-12-31$0-100.0%2025-02-13, From 2022-01-01
2021-12-31$1.43B+164.4%2024-02-15, From 2021-01-01
2020-12-31$539.10M+189.8%2023-02-10, From 2020-01-01
2019-12-31$186.00M-46.9%2022-02-09, From 2019-01-01
2018-12-31$350.04Mn/a2021-02-11, From 2018-01-01
2017-12-31$0n/a2020-02-13, From 2017-01-01
2016-12-31$0n/a2019-02-13, From 2016-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Vertex Pharmaceuticals Inc (VRTX)2025-12-31$2.02B+71.4%
Viatris Inc (VTRS)2025-12-31$500.50M+100.2%
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$3.44B+32.1%
Zoetis Inc. (ZTS)2025-12-31$3.23B+74.1%
Jazz Pharmaceuticals plc (JAZZ)2025-12-31$125.02M-59.9%
Abbott Laboratories (ABT)2025-12-31$893.00M-31.0%
United Therapeutics Corp (UTHR)2025-12-31$1.00B0.0%
Bristol Myers Squibb Co (BMY)2025-12-31$0n/a
Royalty Pharma plc (RPRX)2025-12-31$1.23B+434.5%

Compare VRTX, VTRS, REGN, ZTS side by side · Screen every company in Pharmaceutical Preparations ↗